Post

New research · Ophthalmology
Journal of clinical medicine · 2d
ReviewJournal of clinical medicine · 2026

Low-Concentration Atropine (0.01%, 0.025%, 0.05%) for Myopia Progression in Children: A Systematic Review and Meta-Analysis.

Qi Wan, Qiong Wang, Ran Wei … Ke Ma
Read paper
OphthalmologyReview

0.05% atropine drops slowed myopia progression more than lower doses in children

Low-Concentration Atropine (0.01%, 0.025%, 0.05%) for Myopia Progression in Children: A Systematic Review and Meta-Analysis.

Qi Wan … Ke Ma
Journal of clinical medicine · 2026
Purpose

Myopia has reached epidemic proportions globally, with approximately 50% of the world population projected to be affected by 2050.

Methods

We searched PubMed, Web of Science, Embase, and Cochrane CENTRAL from database inception through April 2026.

n = 1756
Results

0.05% drops boosted eye growth control the most of all doses tested

MD 0.52 (95% CI 0.41 to 0.63)
null 0
0.41
0.63
CI excludes the null - significant
More results

For myopia progression, 0.01% atropine demonstrated significant efficacy at 1 year (pooled MD = +0.291 D, 95% CI: 0.199 to 0.384; p < 0.0001; I 2 = 29.1%) and at 2 years (pooled MD = +0.174 D, 95% CI: 0.056 to 0.291; p = 0.0038; I 2 = 0%).

More results

Clinically, a 0.25 D difference over 1-2 years may translate to approximately 0.50 D cumulative benefit over a typical 5-year treatment course, potentially reducing the risk of high myopia.

All concentrations showed an excellent safety profile with no serious adverse events.

“
Conclusion · 1 of 3

Low-concentration atropine is effective for myopia progression control at all three concentrations, with a concentration-dependent gradient (0.05% > 0.025% > 0.01%).

Conclusion · 2 of 3

The 0.01% concentration offers a reasonable balance of efficacy and tolerability. Further independent validation of the 0.05% concentration is warranted.

Conclusion · 3 of 3

The premyopia prevention indication requires additional well-designed randomized controlled trials.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
44.1%
had too much homocysteine in the blood, a far larger share than in dry AMD or healthy eyes
Cohort Study
92.3%
most laser-treated eyes had a favorable eye-structure outcome
Cohort Study
56%
lost three or more lines on the eye-chart vision test
Cohort Study
50%
older patients were more likely to lose three or more lines of vision
Study
81%
trials where mask air leaks were detected blowing toward the eyes
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Study
379 +/- 156 microm
lower thickness in the central retina, checked with an eye scan
Case Report
9 of 10 eyes
eyes had better measured vision after treatment